07:00 , Oct 6, 2008 |  BC Week In Review  |  Clinical News

Methylphenidate regulatory update

FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) issued a warning letter to Covidien (formerly Mallinckrodt. Inc.) in which the agency said a patient brochure for Methylin mythylphenidate chewable tablets and oral solution overstates...
07:00 , Jun 18, 2007 |  BC Week In Review  |  Company News

Alliant, Sciele deal

SCRX completed its previously announced acquisition of Alliant for $109.8 million in cash and up to $62.5 million in milestones (see BioCentury, April 30, 2007). Alliant Pharmaceuticals Inc., Alpharetta, Ga.   Sciele Pharma Inc. (SCRX), Atlanta,...
07:00 , Apr 30, 2007 |  BC Week In Review  |  Company News

Alliant, Sciele deal

SCRX will acquire Alliant for $122 million in cash and up to $55 million in milestones. SCRX, which develops and markets women’s nutritional supplements and products to treat cardiovascular indications and diabetes, said the move...
08:00 , Jan 8, 2007 |  BioCentury  |  Finance

New products to watch

New products to watch Company Product Indication 2006 approval Alkermes (ALKS)/Cephalon (CEPH) Vivitrol injectable extended-release naltrexone Alcohol dependence U.S. Amgen (AMGN) Vectibix panitumumab Metastatic colorectal cancer U.S. Amylin (AMLN)/Eli Lilly...
07:00 , Sep 4, 2006 |  BC Week In Review  |  Company News

Alliant, BioMarin Pharmaceuticals Inc. sales and marketing update

The partners launched Orapred ODT prednisolone to treat pediatric asthma and reduce inflammation from various inflammatory conditions in the U.S. The launch triggered a $4 million milestone payment to BMRN from Alliant, which has...
07:00 , Jul 3, 2006 |  BioCentury  |  Finance

2Q approvals

2Q approvals 2Q approvals Selected second quarter product approvals. List does not include approvable letters for Nuvigil armodafinil to treat excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome and shift work sleep disorder from...
07:00 , Jun 5, 2006 |  BC Week In Review  |  Clinical News

Orapred ODT prednisolone regulatory update

FDA approved Orapred ODT prednisolone to treat pediatric asthma and reduce inflammation from various inflammatory conditions. Alliant Pharmaceuticals Inc. (Alpharetta, Ga.), which has exclusive North American rights to the Orapred product line, plans to launch...
07:00 , Jun 5, 2006 |  BioCentury  |  Finance

Ebb & Flow

But investors keep returning. This quarter, ISIS has attracted both a new face (Symphony Capital) and a familiar one (Acqua) to its story. Both investors say their due diligence suggests a strong pipeline of second-generation...
00:22 , Jun 2, 2006 |  BC Extra  |  Company News

FDA approves Orapred ODT

FDA approved Orapred ODT prednisolone from BioMarin (BMRN; SWX:BMRN) and Alliant (Alpharetta, Ga.) to treat pediatric asthma and reduce inflammation from various inflammatory conditions. Alliant, which has exclusive North American rights to the Orapred product...
08:00 , Mar 27, 2006 |  BioCentury  |  Finance

BioMarin chronicles

BioMarin chronicles Weekly stock price of BioMarin (BMRN; SWX:BMRN) tracked against selected events since the start of 2004. A. 4/21/04 - BMRN says it will pay $175M for the Ascent Pediatrics business of Medicis...